Page last updated: 2024-12-08
2-hydroxy-1,4-benzoxazin-3-one
Description
2-hydroxy-1,4-benzoxazin-3-one: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
HBOA : A benzoxazine bearing hydroxy and oxo substituents at positions 2 and 3 respectively. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 322636 |
CHEMBL ID | 457386 |
CHEBI ID | 63559 |
SCHEMBL ID | 912962 |
MeSH ID | M0401661 |
Synonyms (22)
Synonym |
nsc280714 |
23520-34-5 |
nsc-280714 |
2-hydroxy-2h-1,4-benzoxazin-3(4h)-one |
2-hydroxy-1,4-benzoxazin-3-one |
hboa |
inchi=1/c8h7no3/c10-7-8(11)12-6-4-2-1-3-5(6)9-7/h1-4,8,11h,(h,9,10 |
CHEMBL457386 |
chebi:63559 , |
2-hydroxy-4h-1,4-benzoxazin-3-one |
2-hydroxy-4h-[1,4]benzoxazin-3-one |
SCHEMBL912962 |
AKOS024287938 |
2-hydroxy-3,4-dihydro-2h-1,4-benzoxazin-3-one |
(r)-2-hydroxy-2h-1,4-benzoxazin-3(4h)-one |
DTXSID00314114 |
Z984801448 |
Q27132690 |
hboa;2-hydroxy-1,4-benzoxazin-3-one |
BCP31437 |
2h-1,4-benzoxazin-3(4h)-one, 2-hydroxy- |
EN300-65795 |
Roles (2)
Role | Description |
allelochemical | A class of secondary metabolites developed by many plants to influence the behaviour, growth or survival of herbivores, and thus acting as a defence against herbivory. |
plant metabolite | Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (3)
Class | Description |
benzoxazine | |
lactam | Cyclic amides of amino carboxylic acids, having a 1-azacycloalkan-2-one structure, or analogues having unsaturation or heteroatoms replacing one or more carbon atoms of the ring. |
lactol | Cyclic hemiacetals formed by intramolecular addition of a hydroxy group to an aldehydic or ketonic carbonyl group. They are thus 1-oxacycloalkan-2-ols or unsaturated analogues. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Bioassays (3)
Assay ID | Title | Year | Journal | Article |
AID338669 | Antiinflammatory activity in Wistar rat peritoneal mast cells assessed as inhibition of IgE-induced histamine release at 1000 uM treated 10 mins before IgE challenge measured after 5 mins | | | |
AID338668 | Antiinflammatory activity in Wistar rat peritoneal mast cells assessed as inhibition of concanavalin A-induced histamine release at 1000 uM treated 10 mins before concanavalin A challenge measured after 30 mins | | | |
AID1103171 | Antifeedant activity against third-instar larvae of Rhopalosiphum padi assessed as repellency index after 24 hr by feeding choice assay | 2004 | Journal of agricultural and food chemistry, May-05, Volume: 52, Issue:9
| Chemical basis for the antifeedant activity of natural hydroxamic acids and related compounds. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (9)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (66.67) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.81
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 11.81 (24.57) | Research Supply Index | 2.56 (2.92) | Research Growth Index | 4.37 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 2 (16.67%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 10 (83.33%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |